TRIPLE HELIX BIOTECHNOLOGY LTD

Follow this company
Executive Summary

Triple Helix Biotechnology Ltd is a start-up biotech company with a stable but modest asset base and low liabilities. The company is currently loss-making with a significant drop in cash reserves over the past year, highlighting liquidity risk. Credit approval is conditional on continued monitoring of cash flow, profitability improvements, and management’s ability to secure additional funding to support ongoing operations.

View Full Analysis Report →

Who controls this company?

Mr Zijie Wang

Correspondence address
12, New Fetter Lane, London, United Kingdom, EC4A 1JP
Date of birth
April 1992
Notified on
2021-11-24
Nationality
Chinese
Country of residence
United Kingdom
 
Source data
Nature of control
Owns between 25% and 50% of the company's shares
Has between 25% and 50% of the voting rights in the company

Mr Da Lin

Correspondence address
12, New Fetter Lane, London, United Kingdom, EC4A 1JP
Date of birth
August 1984
Notified on
2021-11-17
Nationality
British
Country of residence
United Kingdom
 
Source data
Nature of control
Owns between 50% and 75% of the company's shares
Has between 50% and 75% of the voting rights in the company
More Company Information
Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
    • Follow this company